What If Our Cheeks Could
 Speak Volumes?

The ACTIVIZE Trial is evaluating an investigational treatment for adults with mid-face (cheeks) volume loss. By taking part, participants may help researchers better understand potential treatment options for mid-face volume improvement, both now and for the future. Interested in learning more? See if you may qualify today.
See If You May Qualify

You may be able to participate in the ACTIVIZE Trial if you:

Are at least
22 years of age

Have moderate to severe loss of volume in your mid-face (cheeks) (called mid-face volume loss)

Are interested in improving the appearance of your mid-face (cheeks)

Are at least
22 years of age

Have moderate to severe loss of volume in your mid-face (cheeks)

(called mid-face volume deficit)

Are interested in improving the appearance of your mid-face (cheeks)

If you are interested in participating, the trial doctor and team will review additional trial criteria with you.

See If You May Qualify

About the ACTIVIZE Trial

The ACTIVIZE Trial is a clinical trial evaluating an investigational treatment for adults with mid-face (cheeks) volume loss. The goal of the trial is to assess the effects and safety of the investigational treatment to potentially increase volume in the mid-face.

Eligible participants will be assigned randomly (by chance) to a trial group with a 2-out-of-3 chance of receiving the investigational treatment versus the comparator (an already approved treatment). The trial involves approximately 18 trial clinic visits and 3 phone calls over the course of up to 31 months.

Participants may be compensated for travel and expenses.